Clinical Trials
65 trialsClinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)
PharmaMar
innovaTV 301
Seagen Inc.
GRECCAR8
Hospices Civils de Lyon
IROCAS
UNICANCER
CinClare
Fudan University
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
CAIRO5
Dutch Colorectal Cancer Group
LAPIS
Kyntra Bio
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
BeiGene
Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cancer
Jiangsu HengRui Medicine Co., Ltd.
NEOPAN
UNICANCER
BEACON CRC
Pfizer
CanStem303C
Sumitomo Pharma America, Inc.
KEYNOTE-181
Merck Sharp & Dohme LLC
KEYNOTE-181
Merck Sharp & Dohme LLC
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
Children's Oncology Group
TRIPLETE
Gruppo Oncologico del Nord-Ovest
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
Cornerstone Pharmaceuticals
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.
Hoffmann-La Roche
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
Stanford University
Trybeca-1
ERYtech Pharma
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
University of Leeds
Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer
UNICANCER
Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)
EMD Serono
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
National Cancer Institute (NCI)
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Alliance for Clinical Trials in Oncology
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
Children's Oncology Group
Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial
National Institutes of Health Clinical Center (CC)
A Study in Second Line Metastatic Colorectal Cancer
Eli Lilly and Company
AXEPT
Epidemiological and Clinical Research Information Network
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
National Cancer Institute (NCI)
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
SWOG Cancer Research Network
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
Sanofi
FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer
Yonsei University
CRYSTAL
Merck KGaA, Darmstadt, Germany
AFEQT
Sanofi
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC
Japan Clinical Oncology Group
Combination Chemotherapy in Treating Patients With Colorectal Cancer
Alliance for Clinical Trials in Oncology
Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Federation Francophone de Cancerologie Digestive
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
Gustave Roussy, Cancer Campus, Grand Paris
COMETS
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
Pfizer
TRIBE
Gruppo Oncologico del Nord-Ovest
FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
Clinical Research Center for Solid Tumor, Korea